These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11990670)

  • 41. Cerebral syncope: insights from Valsalva maneuver.
    Chuang YM; Hu HH; Pan PJ
    Eur Neurol; 2005; 54(2):98-102. PubMed ID: 16195669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged asystole provoked by head-up tilt testing.
    Winker R; Frühwirth M; Saul P; Rüdiger HW; Pezawas T; Schmidinger H; Moser M
    Clin Res Cardiol; 2006 Jan; 95(1):42-7. PubMed ID: 16598444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of the Time to Syncope Occurrence in Patients Diagnosed with Vasovagal Syncope.
    Kostoglou K; Schondorf R; Benoit J; Balegh S; Mitsis GD
    Acta Neurochir Suppl; 2018; 126():313-316. PubMed ID: 29492581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
    Flevari P; Livanis EG; Theodorakis GN; Zarvalis E; Mesiskli T; Kremastinos DT
    J Am Coll Cardiol; 2002 Aug; 40(3):499-504. PubMed ID: 12142117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug treatment of orthostatic hypotension and vasovagal syncope.
    Frishman WH; Azer V; Sica D
    Heart Dis; 2003; 5(1):49-64. PubMed ID: 12549988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Meta-analysis of beta-adrenoceptor blockers for the treatment of vasovagal syncope].
    Liao Y; Li XY; Zhang YW; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):603-9. PubMed ID: 19088832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
    Gielerak G; Kozłowski D; Dłuzniewska E; Roszczyk A; Cholewa M
    Kardiol Pol; 2003 Feb; 58(2):98-108. PubMed ID: 14504635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced vascular responses to hypocapnia in neurally mediated syncope.
    Norcliffe-Kaufmann LJ; Kaufmann H; Hainsworth R
    Ann Neurol; 2008 Mar; 63(3):288-94. PubMed ID: 17823939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
    Klingenheben T; Credner S; Hohnloser SH
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):276-81. PubMed ID: 10087541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Near-infrared Spectroscopy to Assess Cerebral Perfusion during Head-up Tilt-table Test in Patients with Syncope.
    Ayers MD; Lawrence DK
    Congenit Heart Dis; 2015; 10(4):333-9. PubMed ID: 25421641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed neurally mediated syncope after inferior wall acute myocardial infarction.
    O'Donnell D; Hamer A; Horrigan M
    Am J Cardiol; 2002 Jul; 90(2):157-9. PubMed ID: 12106848
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term outcome of patients with recurrent syncope of unknown cause in the absence of organic heart disease and relation to results of baseline tilt table testing.
    Gatzoulis K; Sideris S; Theopistou A; Sotiropoulos H; Stefanadis C; Toutouzas P
    Am J Cardiol; 2003 Oct; 92(7):876-9. PubMed ID: 14516899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral vasoconstriction in vasovagal syncope: any link with symptoms? A transcranial Doppler study.
    Lagi A; Cencetti S; Corsoni V; Georgiadis D; Bacalli S
    Circulation; 2001 Nov; 104(22):2694-8. PubMed ID: 11723021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A
    Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
    Kaufmann H; Saadia D; Voustianiouk A
    Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced susceptibility to syncope during postural tilt in old age. Is beta-blockade protective?
    Lipsitz LA; Marks ER; Koestner J; Jonsson PV; Wei JY
    Arch Intern Med; 1989 Dec; 149(12):2709-12. PubMed ID: 2574566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systolic blood pressure at rest, not the degree of beta blockade, predicts the result of follow-up tilt-table testing for vasovagal syncope.
    Lewis WR; Carlson MD
    Am J Cardiol; 1997 Aug; 80(3):351-3. PubMed ID: 9264436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
    Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of tilt test in the investigation of syncope].
    Aksnes TA; Nodenes K; Gjesdal K
    Tidsskr Nor Laegeforen; 2000 Mar; 120(7):803-6. PubMed ID: 10806903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.